BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34794221)

  • 1. [The expression of GGCT in the bladder urothelial cell carcinoma and its clinical significance].
    Guo YS; Wu YD; Ma H; Qi L; Zhang SD; Zang YJ
    Zhonghua Zhong Liu Za Zhi; 2021 Nov; 43(11):1183-1187. PubMed ID: 34794221
    [No Abstract]   [Full Text] [Related]  

  • 2. γ-Glutamylcyclotransferase as a novel immunohistochemical biomarker for the malignancy of esophageal squamous tumors.
    Takemura K; Kawachi H; Eishi Y; Kitagaki K; Negi M; Kobayashi M; Uchida K; Inoue J; Inazawa J; Kawano T; Board PG
    Hum Pathol; 2014 Feb; 45(2):331-41. PubMed ID: 24342434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and significance of macrophage migration inhibitory factor in bladder urothelial cell carcinoma].
    Guo YS; Dai YP; Li W; Liu LD
    Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):28-31. PubMed ID: 21575460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sp1 is overexpressed and associated with progression and poor prognosis in bladder urothelial carcinoma patients.
    Zhu J; Lu Z; Ke M; Cai X
    Int Urol Nephrol; 2022 Jul; 54(7):1505-1512. PubMed ID: 35467245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Widespread expression of γ-glutamyl cyclotransferase suggests it is not a general tumor marker.
    Amano T; Eishi Y; Yamada T; Uchida K; Minegishi K; Tamura T; Kobayashi D; Hiroshi K; Suzuki T; Board PG
    J Histochem Cytochem; 2012 Jan; 60(1):76-86. PubMed ID: 22205682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fascin is a predictor for invasiveness and recurrence of urothelial carcinoma of bladder.
    Bi J; Chen X; Zhang Y; Li B; Sun J; Shen H; Kong C
    Urol Oncol; 2012 Sep; 30(5):688-94. PubMed ID: 20888270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of KAI1 metastasis suppressor gene is a recurrence predictor in primary pTa and pT1 urothelial bladder carcinoma.
    Su JS; Arima K; Hasegawa M; Franco OE; Umeda Y; Yanagawa M; Sugimura Y; Kawamura J
    Int J Urol; 2004 Feb; 11(2):74-82. PubMed ID: 14706010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-GA, a Novel Inhibitor of γ-Glutamylcyclotransferase, Suppresses Human Bladder Cancer Cell Growth.
    Hanada E; Kageyama S; Murai R; Kubota S; Ii H; Nakata S; Kita H; Kawauchi A; Chano T
    Anticancer Res; 2019 Apr; 39(4):1893-1898. PubMed ID: 30952730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-level Ki-67 expression as an independent predictor of bladder tumour recurrence in patients with primary upper tract urothelial carcinoma after radical nephroureterectomy.
    Wu P; Liu S; Zhang W; Zhang Y; Zhu G; Wei D; Wan B; Wang J
    Jpn J Clin Oncol; 2015 Dec; 45(12):1175-81. PubMed ID: 26450700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A diagnostic marker for superficial urothelial bladder carcinoma: lack of nuclear ATBF1 (ZFHX3) by immunohistochemistry suggests malignant progression.
    Kawaguchi M; Hara N; Bilim V; Koike H; Suzuki M; Kim TS; Gao N; Dong Y; Zhang S; Fujinawa Y; Yamamoto O; Ito H; Tomita Y; Naruse Y; Sakamaki A; Ishii Y; Tsuneyama K; Inoue M; Itoh J; Yasuda M; Sakata N; Jung CG; Kanazawa S; Akatsu H; Minato H; Nojima T; Asai K; Miura Y
    BMC Cancer; 2016 Oct; 16(1):805. PubMed ID: 27756245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
    Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y
    BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and prognostic value of carbonic anhydrase IX (CA-IX) in bladder urothelial carcinoma.
    Xiang AP; Chen XN; Xu PF; Shao SH; Shen YF
    BMC Urol; 2022 Aug; 22(1):120. PubMed ID: 35922856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.
    Quintero A; Alvarez-Kindelan J; Luque RJ; Gonzalez-Campora R; Requena MJ; Montironi R; Lopez-Beltran A
    J Clin Pathol; 2006 Jan; 59(1):83-8. PubMed ID: 16394286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder.
    Wang B; Wu S; Zeng H; Liu Z; Dong W; He W; Chen X; Dong X; Zheng L; Lin T; Huang J
    J Urol; 2015 Aug; 194(2):556-62. PubMed ID: 25752441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
    Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
    Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
    J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of REG1A, Claudin 7 and Ki67 expressions with tumor recurrence and prognostic factors in superficial urothelial urinary bladder carcinomas.
    Yamuç E; Barışık NÖ; Şensu S; Tarhan F; Barışık CC
    Indian J Pathol Microbiol; 2022; 65(2):355-361. PubMed ID: 35435371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between the expression of E-cadherin and tumor recurrence and progression in high-grade stage T1 bladder urothelial carcinoma.
    Erdemir F; Ozcan F; Kilicaslan I; Parlaktas BS; Uluocak N; Gokce O
    Int Urol Nephrol; 2007; 39(4):1031-7. PubMed ID: 17340210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of replication protein A3 is associated with unfavorable outcome in bladder urothelial carcinoma.
    Sun D; Zhang K; Fu Q; Zhang H; Liu S; Wang H; Xu Z; Wang J
    J Cancer Res Ther; 2021 Jul; 17(3):771-776. PubMed ID: 34269312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.